Stem Cell Clinic

Nadal to have stem cell treatment

By Stem Cell Treatment

Rafael Nadal was bothered by back pain in the Australian Open final. Photo: AFP

Rafael Nadal's doctor says the 14-time grand slam winner will receive stem cell treatment on his ailing back.

Angel Ruiz-Cotorro told AP by phone on Monday that "we are going to put cells in a joint in his spine" next week in Barcelona.

The Spanish tennis star was already sidelined for the rest of the season after having his appendix removed last week.

Ruiz-Cotorro, who has worked as a doctor for Nadal for the past 14 years, said Nadal's back pain is "typical of tennis" players and that the treatment is meant to help repair his cartilage and is similar to stem cell treatment Nadal received on his knee last year.

Advertisement

He said Nadal is expected to return to training in early December.

Several NFL players and baseball players have received stem cell treatment.

Nadal's fellow Spaniard Pau Gasol, centre of the Chicago Bulls, received stem cell treatment on his knee in 2013.

Nadal experienced severe back pain during the final of the Australian Open in January when he lost to Stanislas Wawrinka.

Go here to read the rest:
Nadal to have stem cell treatment

Rafael Nadal to receive stem cell treatment

By Stem Cell Treatment

Rafael Nadal was bothered by back pain in the Australian Open final. Photo: AFP

Rafael Nadal's doctor says the 14-time grand slam winner will receive stem cell treatment on his ailing back.

Angel Ruiz-Cotorro told AP by phone on Monday that "we are going to put cells in a joint in his spine" next week in Barcelona.

The Spanish tennis star was already sidelined for the rest of the season after having his appendix removed last week.

Ruiz-Cotorro, who has worked as a doctor for Nadal for the past 14 years, said Nadal's back pain is "typical of tennis" players and that the treatment is meant to help repair his cartilage and is similar to stem cell treatment Nadal received on his knee last year.

Advertisement

He said Nadal is expected to return to training in early December.

Several NFL players and baseball players have received stem cell treatment.

Nadal's fellow Spaniard Pau Gasol, centre of the Chicago Bulls, received stem cell treatment on his knee in 2013.

Nadal experienced severe back pain during the final of the Australian Open in January when he lost to Stanislas Wawrinka.

Excerpt from:
Rafael Nadal to receive stem cell treatment

Rafael Nadal to undergo stem-cell treatments on his injured back

By Stem Cell Treatment

Rafael Nadal battled a back injury throughout the 2014 season after hurting it during the Australian Open final in January. Its lingered for so long that now hes trying something a little different in his attempt to get back on the court.

Heres the Associated Press:

Rafael Nadals doctor says the 14-time Grand Slam winner will receive stem cell treatment on his ailing back.

Angel Ruiz-Cotorro told The Associated Press by phone on Monday that we are going to put cells in a joint in his spine next week in Barcelona.

The Spanish tennis star was already sidelined for the rest of the season after having his appendix removed last week.

Ruiz-Cotorro, who has worked as a doctor for Nadal for the past 14 years, said Nadals back pain is typical of tennis players and that the treatment is meant to help repair his cartilage and is similar to stem cell treatment Nadal received on his knee last year.

Ruiz-Cotorro continued with the explanation of the treatment:

(Nadal) has a problem typical in tennis with a back joint, he had it at the Australian Open, and we have decided to treat it with stem cells, Ruiz-Cotorro said.

He said that stem cells were recently extracted from Nadal for a cultivation process to produce the necessary quantities.

When we have them we will put them in the point of pain, he said, with the goal of regenerating cartilage, in the midterm, and producing an anti-inflammatory effect.

Visit link:
Rafael Nadal to undergo stem-cell treatments on his injured back

Rafael Nadal to have stem cell treatment on back

By Stem Cell Treatment

Spanish tennis player Rafael Nadal leaves the hospital after successfully undergoing an operation to remove his appendix in Barcelona, Spain, Wednesday, Nov. 5, 2014. (AP Photo/Manu Fernandez) more >

By Joseph Wilson - Associated Press - Monday, November 10, 2014

BARCELONA, Spain Rafael Nadals doctor says the 14-time Grand Slam winner will receive stem cell treatment on his ailing back.

Angel Ruiz-Cotorro told The Associated Press by phone on Monday that we are going to put cells in a joint in his spine next week in Barcelona.

The Spanish tennis star was already sidelined for the rest of the season after having his appendix removed last week.

Ruiz-Cotorro, who has worked as a doctor for Nadal for the past 14 years, said Nadals back pain is typical of tennis players and that the treatment is meant to help repair his cartilage and is similar to stem cell treatment Nadal received on his knee last year.

He said Nadal is expected to return to training in early December.

Several NFL players and baseball players have received stem cell treatment. Nadals fellow Spaniard Pau Gasol, center of the Chicago Bulls, received stem cell treatment on his knee in 2013.

Nadal experienced severe back pain during the final of the Australian Open in January when he lost to Stanislas Wawrinka.

(Nadal) has a problem typical in tennis with a back joint, he had it at the Australian Open, and we have decided to treat it with stem cells, Ruiz-Cotorro said.

See the rest here:
Rafael Nadal to have stem cell treatment on back

Fall & Winter 2014 Stem Cell Research Update| Bedford Stem …

By Stell Cell Research

In the body, the daily pattern of light and dark controls many signals sent out by the brain, such as those that trigger changes in body temperature, and feelings of hunger and sleepiness.

Stem cells may especially need circadian signals to differentiate into specific cell types, such as neurons or bone marrow but what type of signal should they receive in the laboratory? And what frequency? There is growing evidence that each type of cell needs a different circadian signal.

To answer this question, Bedford Research scientists have taken advantage of a genetically engineered mouse that has the firefly glow gene (Luciferase) attached to one of the circadian rhythm genes (the Period 2 gene). Tissues in this PerLuc mouse glow when Period 2 is active.

Until this fall, Bedford Research scientists have been unable to discover the circadian signal needs of their two new lines of stem cells from the PerLuc mouse because of the lack of a microscope sensitive enough to detect and photograph the glow of a small number of cells.

The good news is that such a microscope has been developed, and this year became available in the U.S. The bad news is that the system costs $160,000 and is not yet available anywhere on the east coast.

Olympus loaned Bedford Research scientists a demonstration LV200 for a couple of weeks this fall during which we discovered that our PerLuc stem cells do, indeed glow (Figure 1), and that the glow actually begins soon after egg activation, and increases with the transition into stem cells (Figure 2).

View post:
Fall & Winter 2014 Stem Cell Research Update| Bedford Stem ...

BioEden the specialist tooth stem cell bank announce record sales up 45%

By Stem Cell Medicine

(PRWEB UK) 9 November 2014

Every day stem cell treatments are in the news, often bringing the last hope for many patients with serious conditions that have defied traditional medicine.

BioEden's Group CEO Tony Veverka says, 'the increase in popularity in banking a persons own cells is as a result of two main things; 1. The likelihood of needing stem cell therapy is high, and 2. You need a stem cell match - your own cells are the perfect match'.

BioEden's tooth stem cell banking service is the only way you can access your own cells without the need for medical intervention. More and more parents are choosing to bank their children's stem cells as the baby tooth is shed naturally. However, stem cells can be banked from a healthy adult molar, that perhaps is being removed for orthodontic reasons.

Obtaining stem cells from other sources such as bone marrow is not only invasive but costly. Taking the decision to bank ones own cells is a sensible consideration, and costs from just 295.

See more here:
BioEden the specialist tooth stem cell bank announce record sales up 45%

Dexamethasone administered to Chong Wei by specialist clinic: Minister

By Stem Cell Clinic

PUTRAJAYA - The banned substance dexamethasone was not administered to Datuk Lee Chong Wei by doctors at the National Sports Institute (ISN) but a specialist sports clinic in Kuala Lumpur as part of stem cell treatment for an injury, said Youth and Sports Minister Khairy Jamaluddin.

"Dexamethasone is allowed for athletes seeking treatment for injuries.

"It usually last in the body for 10 days but in this case we are not sure why it lasted longer than that," he told reporters after attending the launching of the GeNexter Carnival 2014 in Putrajaya, Sunday.

Khairy said the National Sports Institute had referred Chong Wei to the clinic.

With regard the progress of the Badminton World Federation (BWF), Khairy said that preparations are being made with updates to be made known in due course.

Chong Wei, 32, was tested positive for dexamethasone during a random doping test at the World Championships in Copenhagen, Denmark in August. Dexamethasone is not a performance-enhancing drug but a type of steroid medication with anti-inflammatory effects that is usually used to aid an athlete's rehabilitation.

Read more from the original source:
Dexamethasone administered to Chong Wei by specialist clinic: Minister

Parkinson's stem cell therapy works in rats

By Stem Cell Treatment

Dopamine-making neurons derived from human embryonic stem cells.

A rat model of Parkinson's disease has been successfully treated with neurons derived from human embryonic stem cells, according to a study led by Swedish scientists. Its a promising sign for scientists at The Scripps Research Institute and Scripps Health who hope to perform similar therapy on Parkinsons patients, using artificial embryonic stem cells.

In rats and people, neurons that make the neurotransmitter dopamine are essential for normal movement. The cells are destroyed in Parkinson's, leading to the difficulty in movement that characterizes the disease.

Researchers transplanted dopamine-producing cells grown from human embryonic stem cells into the brains of rats whose own dopamine-making neurons had been destroyed. The rats were immune-suppressed so they would not reject the cells. Within five months, the transplanted cells boosted dopamine production to normal levels, restoring normal movement in the rats.

The study was published Thursday in the journal Cell Stem Cell. The senior author was Malin Parmar of Lund University in Lund, Sweden.

The results support the Scripps approach of using the artificial embryonic stem cells, called induced pluripotent stem cells, said Jeanne Loring, who heads the Center for Regenerative Medicine at The Scripps Research Institute in La Jolla. Loring is part of a group called Summit 4 Stem Cell that's raising funds to treat eight Parkinson's patients with their own IPS cells.

Particularly significant is the study's comparison of the effects of dopamine-making neurons derived from fetal cells to that of embryonic stem cells, Loring said by email.

"In the 1980s and 1990s, there were several clinical trials that showed that grafts of fetal brain containing the precursors of dopamine neurons could reverse the effects of Parkinson's disease in some patients," Loring said. "We, and the others developing stem cell therapies, based our plans on the results of those studies, but no one had ever directly compared fetal tissue and human pluripotent stem cell-derived dopamine neurons in an animal model of PD."

Induced pluripotent stem cells appear to have much the same capacity as human embryonic stem cells to generate different tissues and organs.

There has been uncertainty about how similar they are to each other, specifically whether the IPS process produces mutations. But recent studies have found the cell types are extremely similar, including a study also published in Cell Stem Cell on Thursday. That study compared IPS cells with embryonic stem cells produced by SCNT, or somatic cell nuclear transfer, the same process used to create Dolly the sheep.

See the article here:
Parkinson's stem cell therapy works in rats

→←